MIMS Online

A quarter of older patients can discontinue levothyroxine successfully, researchers find Read more on MIMS buff.ly/qZTJo2U

This week's news in brief: ▶️ New oral GLP-1 agonist under MHRA review ▶️ GLP-1 adverse events differ by indication, large-scale analysis finds Read more on MIMS buff.ly/harLZlf

Thousands of new pharmacist prescribers face 'worrying barriers' to helping the NHS shift more care into the community, a new report warns. Read more on MIMS buff.ly/ACr3ArC

This week's #drugshortages ▶️ Aztreonam 2g powder for solution for injection in vials: Kent Pharmaceuticals ▶️ Domperidone Suspension, 1mg/ml: Zentiva ▶️ Malarone (atovaquone/proguanil) For more information, see the MIMS Drug Shortages Tracker buff.ly/CSsYVep

Two more continuous glucose monitoring sensors can be prescribed for eligible patients. Read more on MIMS buff.ly/QPqA5pe

The head of NHS England has said that he is 'really worried' about potential disruption to medicines supply as a result of the war in Iran buff.ly/Qlwu7Xd

Wegovy (semaglutide) has been recommended by NICE to help prevent heart attack and stroke in people who have already experienced such an event or have peripheral arterial disease and who are also overweight. Read more on MIMS buff.ly/HSad70g

This week's #drugshortages ▶️ Bexsero (meningitis B vaccine) ▶️ Chlordiazepoxide 5mg and 10mg capsules: Viatris ▶️ Conotrane (benzalkonium chloride/dimeticone) For more information, see the MIMS Drug Shortages tracker buff.ly/z4EKhdy

SSRI provides ‘consistent and meaningful benefits’ in long COVID, trial finds. Read more on MIMS: buff.ly/fyLDqoC

A new pressurised metered-dose salbutamol inhaler, Asthalin, has been launched in the UK. Read more on MIMS buff.ly/RY2FJee

This week's news in brief ▶️ Additional meningitis vaccine stock released for private supply Read more on MIMS buff.ly/KOqSq1k

NHS clinicians should inform providers and patients seeking a private GLP-1 drug prescription of any potential safety issues, a clinical pharmacist has said in a new webinar buff.ly/ycQMdD3

This week's #drugshortages ▶️ Trumenba (meningococcal group B vaccine) ▶️ Aceclofenac 100mg tablets: various ▶️ Fluomizin (dequalinium) For more information, see the MIMS Drug Shortages Tracker buff.ly/z4EKhdy

Community and primary care teams will be supported to diagnose and treat patients with asthma and COPD closer to home, in a new national partnership between the NHS and the pharmaceutical industry, the DHSC has announced. Read more on MIMS buff.ly/P2Nca4d

Donanemab and lecanemab will be re-evaluated for NHS use after being rejected in draft NICE guidance last year. Read more on MIMS buff.ly/o830G3s

This week's news in brief ▶️ GLP-1 use in early pregnancy may not cause complications in women without diabetes Read more on MIMS buff.ly/jTIKxpE

Trackers covering product presentation changes, nutritional product shortages, and NICE decisions are now available to MIMS subscribers. Read more on MIMS buff.ly/UPPSLSy

This week's #drugshortages ▶️ Betnovate RD 0.025% cream (betamethasone) ▶️ Co-trimoxazole Paediatric Suspension, 40mg/200mg per 5ml: various ▶️ Ramipril Capsules, 1.25mg: various For more information, see the MIMS Drug Shortages tracker buff.ly/DCQ0Mbg

The use of anxiolytic medication was strongly associated with mortality in people with dementia in a case-controlled study. Read more on MIMS buff.ly/YJoyDiL

A once-daily, dual therapy, dry powder inhaler was associated with slightly improved COPD outcomes compared with a twice-daily, dual therapy, metered dose inhaler and a twice-daily, dual therapy, dry powder inhaler in a cohort study. Read more on MIMS buff.ly/oyMv07u